Synergistic effects between catalase inhibitors and modulators of nitric oxide metabolism on tumor cell apoptosis

Anticancer Research

Volumn 34, Issue 10, 2014, Pages 5337-5350

  Scheit, Katrin ^a   Bauer, Georg ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Apoptosis; Ascorbic acid; Catalase; Interferon; Nitric oxide; Nitric oxide dioxygenase; ROS signaling; Salicylic acid; Singlet oxygen

Indexed keywords

ALLYL ISOTHIOCYANATE; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; ARGININE; ARTEMISININ; ASCORBIC ACID; BETA INTERFERON; CASPASE 8; CASPASE 9; CATALASE INHIBITOR; CYCLOHEXIMIDE; DIALLYL DISULFIDE; GAMMA INTERFERON; ISOXANTHINE; ISOXANTHOHUMOL; ITRACONAZOLE; METHYLDOPA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE METABOLISM MODULATOR; NITRIC OXIDE SYNTHASE; QUERCETIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SALICYLIC ACID; SINGLET OXYGEN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; XANTHINE; XANTHOHUMOL; ANTHOCYANIN; CATALASE; CYANIDIN; ENZYME INHIBITOR; NITRIC OXIDE DIOXYGENASE; OXYGENASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; STOMACH ADENOCARCINOMA; ANTAGONISTS AND INHIBITORS; DOSE RESPONSE; DRUG EFFECTS; GENETICS; METABOLISM; NEOPLASM; RNA INTERFERENCE; TUMOR CELL LINE;

ANTHOCYANINS; APOPTOSIS; CASPASE 8; CATALASE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; HUMANS; NEOPLASMS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXYGENASES; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SALICYLIC ACID;

EID: 84917710469     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Bechtel W and Bauer G: Catalase protects tumor cells against apoptosis induction by intercellular ROS signaling. Anticancer Res 29: 4541-4557, 2009.
2. Heinzelmann S and Bauer G: Multiple protective functions of catalase against intercellular apoptosis-inducing ROS signaling of human tumor cells. Biol Chem 391: 675-693, 2010.
3. Bauer G. Tumor cell protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling. Anticancer Res 32: 2599-2624, 2012.
4. Bauer G: Targeting extracellular ROS signaling of tumor cells. Anticancer Res 34: 1467-1482, 2014.
5. Deichman GI and Vendrov EL: Characteristics of in vitro transformed cells essential for their in vivo survival, selection and metastatic activity. Int J. Cancer 37: 401-409, 1986.
6. Deichman GI, Kluchareva TE, Matveeva VA, Kushlinsky NE, Bassalyk LS and Vendrov EL: Clustering of discrete cell properties essential for tumorigenicity and metastasis. I. Studies of syrian hamster embryo fibroblasts spontaneously transformed in vitro. Int J Cancer 44: 904-907, 1989.
7. Deichman G, Matveeva VA, Kashkina LM, Dyakova NA, Uvarova EN, Nikiforov MA and Gudkov AV: Cell transforming genes and tumor progression: in vivo unified secondary phenotypic cell changes. Int J Cancer 75: 277-283, 1998.
8. Deichman G: Natural selection and early changes of phenotype of tumor cells in vivo: Acquisition of new defense mechanisms. Biochem (Mosc) 65: 78-94, 2000.
9. Deichman G: Early phenotypic changes of in vitro transformed cells during in vivo progression: possible role of the host innate immunity. Sem Cancer Biol 12: 317-326, 2002.
10. Herdener M, Heigold S, Saran M and Bauer G: Target cellderived superoxide anions cause efficiency and selectivity of intercellular induction of apoptosis. Free Rad Biol Med 29: 1260-1271, 2000.
11. Heigold S, Sers C, Bechtel W, Ivanovas B, Schäfer R and Bauer G: Nitric oxide mediates apoptosis induction selectively in transformed fibroblasts compared to nontransformed fibroblasts. Carcinogenesis 23: 929-941, 2002.
12. 2-. Implication for the action of endothelium-derived relaxing factor (EDRF). Free Rad Res Comm 10: 221-226, 1990.
13. Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H and Beckman JS: Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 5: 834-842, 1992.
14. Huie RE and Padmaja S: The reaction of NO with superoxide. Free Rad Res Comm 18: 195-199, 1993.
15. Pryor WA and Squadrito GL: The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 268: L699-L722, 1995.
16. 2.-: a pulse radiolysis study. Free Rad Biol Med 19: 505-510, 1995.
17. Beckman JS, Beckman TW, Chen J, Marshall PA and Freeman BA: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury form nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624, 1990.
18. Gatti RM, Alvarez B, Vasquez-Vivar J, Radi R and Augusto O: Formation of spin trap adducts during the decomposition of peroxynitrate. Arch Biochem Biophys 349: 36-46, 1998.
19. Goldstein S, Meyerstein D, van Eldik R and Czapski G: Peroxynitrous acid decomposes via homolysis: evidence from high-pressure pulse radiolysis. J Phys Chem A 103: 6587-6590, 1999.
20. 2 radicals. Chem Res Toxicol 11: 712-713, 1998.
21. Hou D-X, Fujii M, Terahara N and Yoshimote M: Molecular mechanisms behind the chemopreventiv effects of anthocyanidins, J Biomed Biotechnol 2004:5: 321-325, 2004.
22. Chang Y-C, Huang H-P, Hsu J-D, Yang S-F and Wang C-J: Hibiscus anthocyanins rich extract-induced apoptotic cell death in human promyelocytic leukemia cells. Tox Appl Pharmacol 205: 201-212, 2005.
23. Chen P-N, Chu S-C, Chiou H-L, Chiang C-L, Yang S-F and Hsieh Y-S: Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutrition and Cancer 53: 232-243, 2005.
24. Shih P-H, Yeh C-T, Yen G-C: Effects of anthocyanidin on the inhibition of proliferation and induction of apoptosis in human gastric adenocarcinoma cells. Food and Chem Toxicol 43: 1557-1566, 2005.
25. Feng R, Ni H-M, Wang SY, Tourkova IL, Shurin MR and Harada H: Cyanidin-3-rutinoside, a natural polyphenol antioxidant, selectively kills leukemic cells by induction of oxidative stress. J Biol Chem 282: 13468-13476, 2007.
26. Reddivari L, Vanamala J, Chintharlapalli S, Safe SH and Creighton JC: Anthocyan fraction from potato extracts is cytotoxid to prostate cancer cells through activation of caspase-dependent and caspase-independent pathways. Carcinogenesis 28: 2227-2235, 2007.
27. Wang L-S and Stoner GD: Anthocyanins and their role in cancer prevention. Cancer Letters 269: 281-290, 2008.
28. Aas AT, Tønnessen TI, Brun A and Salford LG: Growth inhibition of rat glioma cells in vitro and in vivo by aspirin. J Neuro-Oncol 24: 171-180, 1995.
29. Bellosillo B, Pique M, Barragan M, Dastano E, Villamor N, Colomer D, Montserrat E, Pons G and Gil J: Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 4: 1406-1414, 1998.
30. Klampfer L, Cammenga J, Wisniewski H-G and Nimer SD: Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines. Blood 93: 2386-2394, 1999.
31. Chung YM, Bae YS and Lee SY: Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis. Free Radic Biol Med 34: 434-442, 2003.
32. Battaglia V, Salvi M and Toninello A: Oxidative stress is responsible for mitochondrial permeability transition induction by salicylate in liver mitochondria. J Biol Chem 280: 33864-33872, 2005.
33. Elwood PC, Gallagher AM, Duthie GG, Mur LAJ and Morgan G: Aspirin, salicylates, and cancer. Lancet 373: 1301-1309, 2009.
34. Elder DJE, Hague A, Hicks DJ and Paraskeva C: Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res 56: 2273-2276, 1996.
35. Rao CV, Rivenson A, Simi B. Zang E, Kelloff G. Steele Van and Reddy BS: Chemoprevention of colon carcinogenesis by sulindac, a non-steroidal anti-inflammatory agent. Cancer Res 55: 1464-1472, 1995.
36. Giardiello FM, Offerhaus GJA and DjuBois RN: The role of non-steroidal anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer 31A: 1071-1076, 1995.
37. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T and Goldschmidt-Clermont PJ: Mitogenic signalling by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652, 1997.
38. Irani K and Goldschmidt-Clermont PJ: Ras, superoxide and signal transduction. Biochem Pharmacol 55: 1339-1346, 1998.
39. Durner J, Klessig DF: Salicylic acid is a modulator of tobacco and mammalian catalases. J Biol Chem 271: 28492-28501, 1996.
40. Brown GC: Reversible binding and inhibition of catalase by nitric oxide. Eur J Biochem 232: 188-191, 1995.
41. Di Mascio P, Bechara EJH, Medeiros MHG, Briviba K and Sies H: Singlet molecular oxygen production in the reaction of peroxynitrite with hydrogen peroxide. FEBS Lett 355: 287-289, 1994.
42. Zhuang S, Demir JT and Kochevar IE: Protein kinase C inhibits singlet oxygen-induced apoptosis by decreasing caspase-8 activation. Oncogene 20: 6764-6776, 2001.
43. Suzuki Y, Ono Y and Hirabayashi Y: Rapid and specific reactive oxygen species generation via NADPH oxidase activation during FAS-mediated apoptosis. FEBS Lett 425: 209-212, 1998.
44. Reinehr R, Becker S, Eberle A, Grether-Beck S and Häussinger D: Involvement of NADPH oxidase isoforms and src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem 280: 27179-27194, 2005.
45. Selleri C, Sato T, Raiola AM, Rotoli B, Young NS and Maciejewski JP: Induction of nitric oxide synthase is involved in the mechanism of FAS-mediated apoptosis in hematopoietic cells. Br J Hematol 99: 481-489, 1997.
46. Escobar JA, Rubio A and Lissi EA: SOD and catalase inactivation by singlet oxygen and peroxyl radicals. Free Rad Biol Med 20: 285-290, 1996.
47. Kim YK, Kwon OJ and Park J-W: Inactivation of catalase and superoxide dismutase by singlet oxygen derived from photoactivated dye. Biochimie 83: 437-444, 2001.
48. Fita I and Rossmann MG: The active center of catalase. J Mol Biol 185: 21-37, 1985.
49. Ophoven SJ and Bauer G: Salen-manganese complexes: sophisticated tools for the study of intercellular ROS signaling. Anticancer Res 30: 3967-3980, 2010.
50. Kerr, JFR, Wyllie AH, and Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
51. Elmore S: Apoptosis: A review of programmed cell death. Toxicol Pathol 35: 495-515, 2007.
52. Bauer G, Bereswill S, Aichele P and Glocker E: Helicobacter pylori protects protects oncogenically transformed cells from reactive oxygen species-mediated intercellular induction of apoptosis. Carcinogenesis 35: 1582-1591, 2014.
53. Beck E, Schäfer R and Bauer G: Sensitivity of transformed fibroblasts for intercellular induction of apoptosis is determined by their transformed phenotype. Exp. Cell Res 234: 47-56, 1997.
54. Jürgensmeier J, Schmitt CP, Viesel E, Höfler P and Bauer G: TGF-β-treated normal fibroblasts eliminate transformed fibroblasts by induction of apoptosis. Cancer Res 54: 393-398, 1994.
55. Temme J and Bauer G: Low-dose gamma irradiation enhances superoxide anion production by nonirradiated cells through TGF-β1-dependent bystander signaling. Rad Res 179: 422-432, 2013.
56. Davison AJ, Kettle AJ and Fatur DJ: Mechanism of the inhibition of catalase by ascorbate. J Biol Chem 261: 1193-2000, 1986.
57. Jones DP, Meyer DB, Andersson B and Orrenius S: Conversion of catalase to the secondary catalase-peroxide complex (compound II) by α-methyldopa. Mol Pharmacol 20: 159-164, 1981.
58. Hallstrom CK, Gardner AM and Gardner PR: Nitric oxide metabolism in mammalian cells: substrate and inhibitor profiles of a NADPH-cytochrome P450 oxidoreductase-coupled microsomal nitric oxide dioxygenase. Free Rad Biol Med 37: 216-228, 2004.
59. Sharara AI, Perkins DJ, Misukonis MA, Chan SU, Dominitz JA and Weinberg JB: Interferon (IFN)- α activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationships of induced NOS2 to the anti-Hepatitis C effects of INF- α in vivo. J Exp Med 186: 1495-1502, 1997.
60. Fujihara M, Ito N, Pace JL, Watanabe Y, Russell SW and Suzuki T: Role of endogenous interferon-beta in lipopolysaccharide-triggered activation of the inducible nitric-oxide synthase gene in a mouse macrophage cell line, J774. J Biol Chem 269: 12773-12778, 1994.
61. Karupiah G, Cie Q-W, Buller RML, Nathan C, Duarte C and MacMicking JD: Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261: 1445-1448, 1993.
62. Kono Y and Fridovich I: Superoxide radical inhibits catalase. J Biol Chem 257: 5751-5754, 1982.
63. Shimizu N, Kobayashi K and Hayashi K: The reaction of superoxide radical with catalase. Mechanism of the inhibition of catalase by superoxide radical. J Biol Chem 259: 4414-4418, 1984.
64. Fridovich I: Biological effects of the superoxide radical. Arch Biochem Biophys 247: 1-11, 1986.
65. 2.- with catalase and its compound I. Int J Rad Biol 55: 45-50, 1989.
66. Pigeolet E, Corbisier P, Houbion A, Lambert D, Michiels C, Raes M, Zachary M-D and Remacle J: Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Development 51: 283-297, 1990.
67. Gardner PR, Martin LA, Hall D and Gardner AM: Dioxygen-dependent metabolism of nitric oxide in mammalian cells. Free Rad Biol Med 31: 191-204, 2001
68. Schmidt K and Mayer B: Consumption of nitric oxide by endothelial cells: Evidence for the involvement of a NAD(P)H-, flavin and heme-dependent dioxygenase reaction. FEBS Lett 577: 199-204, 2004.
69. Gardner PR: Assay and characterization of the NO dioxygenase activity of flavohemoglobins. In: Globins and Other Nitric Oxide-reactive Proteins. Meth Enzymol 436: 217-237, 2008.